Correlation Between Zentalis Pharmaceuticals and Pharvaris
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Pharvaris BV, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Pharvaris.
Diversification Opportunities for Zentalis Pharmaceuticals and Pharvaris
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Zentalis and Pharvaris is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Pharvaris go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Pharvaris
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to under-perform the Pharvaris. In addition to that, Zentalis Pharmaceuticals is 1.71 times more volatile than Pharvaris BV. It trades about -0.08 of its total potential returns per unit of risk. Pharvaris BV is currently generating about 0.06 per unit of volatility. If you would invest 1,890 in Pharvaris BV on August 28, 2024 and sell it today you would earn a total of 479.00 from holding Pharvaris BV or generate 25.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Pharvaris BV
Performance |
| Timeline |
| Zentalis Pharmaceuticals |
| Pharvaris BV |
Zentalis Pharmaceuticals and Pharvaris Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zentalis Pharmaceuticals and Pharvaris
The main advantage of trading using opposite Zentalis Pharmaceuticals and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.| Zentalis Pharmaceuticals vs. Eliem Therapeutics | Zentalis Pharmaceuticals vs. Scpharmaceuticals | Zentalis Pharmaceuticals vs. Milestone Pharmaceuticals | Zentalis Pharmaceuticals vs. Seres Therapeutics |
| Pharvaris vs. Pmv Pharmaceuticals | Pharvaris vs. Eliem Therapeutics | Pharvaris vs. MediciNova | Pharvaris vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |